Artificial intelligence techniques for colorectal cancer drug metabolism: Ontologies and complex networks

Current Drug Metabolism

Volumn 11, Issue 4, 2010, Pages 347-368

  Martínez Romero, Marcos ^a   Vázquez Naya, José M ^a   Rabuñal, Juan R ^a   Pita Fernández, Salvador ^b   Macenlle, Ramiro ^c   Castro Alvariño, Javier ^d   López Roses, Leopoldo ^e   Ulla, José L ^f   Martínez Calvo, Antonio V ^f   Vázquez, Santiago ^g   Pereira, Javier ^a   Porto Pazos, Ana B ^a   Dorado, Julián ^a   Pazos, Alejandro ^a   Munteanu, Cristian R ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c Instituto de Investigación Biomédica Ourense Vigo Pontevedra   (Spain)

^d Universidad de La Coruña   (Spain)

^e HOSPITAL XERAL CALDE   (Spain)

^f Complejo Hospitalario Montecelo de Pontevedra ^*  (Spain)

^g HOSPITAL POVISA   (Spain)

Author keywords

Colorectal cancer; Complex network; Drug metabolic pathway; Graphs; Ontology

Indexed keywords

5 ETHYNYLURACIL; ACETYLSALICYLIC ACID; CAPECITABINE; CARBOPLATIN; CELECOXIB; CETUXIMAB; CISPLATIN; CYANOCOBALAMIN; CYCLOOXYGENASE 2 INHIBITOR; CYCLOPHOSPHAMIDE; CYTOCHROME P450 2C19; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OMEPRAZOLE; OXALIPLATIN; PACLITAXEL; RITUXIMAB; TEGAFUR; TRASTUZUMAB; URACIL;

ADVANCED CANCER; ARTIFICIAL INTELLIGENCE; BIOCHEMISTRY; BIOINFORMATICS; BIOMEDICINE; BREAST CANCER; CANCER CELL; CANCER SURVIVAL; CHROMOSOME INSERTION; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; DRUG DOSE REDUCTION; DRUG MECHANISM; DRUG METABOLISM; FOLLICULAR LYMPHOMA; GENE MUTATION; GLUCOSE METABOLISM; HUMAN; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; OTOTOXICITY; PHARMACOGENETICS; PROGRESSION FREE SURVIVAL; REVIEW;

ANTINEOPLASTIC AGENTS; ARTIFICIAL INTELLIGENCE; COLORECTAL NEOPLASMS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, THEORETICAL;

EID: 77953299848     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920010791514289     Document Type: Review

References (230)

1. Welsh, J. B.; Sapinoso, L. M.; Su, A. I.; Kern, S. G.; Wang-Rodriguez, J.; Moskaluk, C. A.; Frierson, H. F., Jr.; Hampton, G. M. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res., 2001, 61, 5974-5978
2. Rivera, M. P.; Stover, D. E. Gender and lung cancer. Clin. Chest Med., 2004, 25, 391-400.
3. Kirkegaard, T.; McGlynn, L. M.; Campbell, F. M.; Muller, S.; Tovey, S. M.; Dunne, B.; Nielsen, K. V.; Cooke, T. G.; Bartlett, J. M. Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients. Clin. Cancer Res., 2007, 13, 1405-1411
4. Jain, K. K. Recent advances in clinical oncoproteomics. J. Buon., 2007, 12 (Suppl 1), S31-8.
5. Jeong, H.; Tombor, B.; Albert, R.; Oltvai, Z. N.; Barabasi, A. L. The large-scale organization of metabolic networks. Nature, 2000, 407, 651-654
6. Estrada, E. Generalization of topological indices. Chem. Phys. Lett., 2001, 336, 248-252.
7. González-Díaz, H.; González-Díaz, Y.; Santana, L.; Ubeira, F. M.; Uriarte, E. Proteomics, networks and connectivity indices. Proteomics, 2008, 8, 750-778.
8. Todeschini, R.; Consonni, V. Handbook of Molecular Descriptors. Wiley-VCH, Weinheim, 2002.
9. Mandado, M.; Gonzáles-Moa, M. J.; Mosquera, R. A. Chemical Graph Theory and n-Center Electron Delocalization indices: a study on polycyclic aromatic hydrocarbons. J. Comput. Chem., 2007, 28, 1625-1633.
10. González-Díaz, H.; Ferino, G.; Podda, G.; Uriarte, E. Discriminating Prostate Cancer Patients from control group with connectivity indices. ECSOC, 2007, 11, G1:1-10.
11. González-Díaz, H.; Vina, D.; Santana, L.; de Clercq, E.; Uriarte, E. Stochastic entropy QSAR for the in silico discovery of anticancer compounds: prediction, synthesis, and in vitro assay of new purine carbanucleosides. Bioorg. Med. Chem., 2006, 14, 1095-1107
12. Chou, K. C. Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady-state systems. Biophys. Chem., 1990, 35, 1-24.
13. Chou, K. C. Graphical rules in steady and non-steady enzyme kinetics. J. Biol. Chem., 1989, 264, 12074-12079.
14. Chou, K. C. Review: Applications of graph theory to enzyme kinetics and protein folding kinetics. Steady and non-steady state systems. Biophys. Chem., 1990, 35, 1-24.
15. Chou, K. C. Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes. Bioinformatics, 2005, 21, 10-19
16. Chou, K. C.; Forsen, S. Graphical rules for enzyme-catalyzed rate laws. Biochem. J., 1980, 187, 829-835.
17. Randič, M.; Vračko, M.; Nandy, A.; Basak, S. C. On 3-D graphical representation of DNA primary sequences and their numerical characterization. J. Chem. Inf. Comput. Sci., 2000, 40, 1235-1244.
18. González-Díaz, H.; Vilar, S.; Santana, L.; Uriarte, E. Medicinal chemistry and bioinformatics - current trends in drugs discovery with networks topological indices. Curr. Top. Med. Chem., 2007, 7, 1025-1039
19. Estrada, E. Application of a novel graph-theoretic folding degree index to the study of steroid-DB3 antibody binding affinity. Comput. Biol. Chem., 2003 27, 305-313.
20. Liao, B.; Wang, T. M. New 2D graphical representation of DNA sequences. J. Comput. Chem., 2004, 25, 1364-1368
21. Chou, K. C. Review: structural bioinformatics and its impact to biomedical science. Curr. Med. Chem., 2004, 11, 2105-2134
22. González-Díaz, H.; Cruz-Monteagudo, M.; Molina, R.; Tenorio, E.; Uriarte, E. Predicting multiple drugs side effects with a general drug-target interaction thermodynamic Markov model. Bioorg. Med. Chem., 2005, 13, 1119-1129 (Pubitemid 40164596)
23. Kier, L. B.; Bonchev, D.; Buck, G. A. Modeling biochemical networks: a cellular-automata approach. Chem. Biodivers, 2005, 2, 233-243
24. Loftsson, T.; Thorsteinsson, T.; Masson, M. Hydrolysis kinetics and QSAR investigation of soft antimicrobial agents. J. Pharm. Pharmacol., 2005, 57, 721-727
25. Mekenyan, O. G.; Dimitrov, S. D.; Pavlov, T. S.; Veith, G. D. A systematic approach to simulating metabolism in computational toxicology. I. The TIMES heuristic modelling framework. Curr. Pharm. Des., 2004, 10, 1273-1293
26. Rush, T. S., 3rd; Grant, J. A.; Mosyak, L.; Nicholls, A. A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. J. Med. Chem., 2005, 48, 1489-1495
27. Chou, K. C.; Cai, Y. D. Predicting protein-protein interactions from sequences in a hybridization space. J. Proteome Res., 2006, 5, 316-322
28. Chen, X. W.; Liu, M. Prediction of protein-protein interactions using random decision forest framework. Bioinformatics, 2005, 21, 4394-4400
29. Chen, R.; Weng, Z. A novel shape complementarity scoring function for protein-protein docking. Proteins, 2003, 51, 397-408.
30. Bonchev, D. Complexity analysis of yeast proteome network. Chem. Biodivers., 2004 1, 312-326
31. J.F. Sharom, D. S. B., M. Tyers. From large networks to small molecules. Curr. Opin. Chem. Biol., 2004, 8, 81-90.
32. Shibata, M.; Zielinski, T. J. Computer graphics presentations and analysis of hydrogen bonds from molecular dynamics simulation. J. Mol. Graph, 1992, 10, 88-95, 107-109
33. Jalbout, A. F.; Solimannejad, M. Reliability of gaussian based ab initio methods in the calculations of HClO and HOCl decomposition channels. J. Mol. Struct., 2003, 626, 87-90.
34. Andraos, J. Kinetic plasticity and the determination of product ratios for kinetic schemes leading to multiple products without rate laws: new methods based on directed graphs. Can. J. Chem., 2008, 86, 342-357.
35. Chou, K. C.; Zhang, C. T. Diagrammatization of codon usage in 339 HIV proteins and its biological implication. AIDS Res. Hum. Retroviruses, 1992, 8, 1967-1976.
36. Qi, X. Q.; Wen, J.; Qi, Z. H. New 3D graphical representation of DNA sequence based on dual nucleotides. J. Theor. Biol., 2007, 249, 681-690
37. Liao, B.; Xiang, X.; Zhu, W. Coronavirus phylogeny based on 2D graphical representation of DNA sequence. J. Comput. Chem., 2006, 27, 1196-1202.
38. Randic, M. Condensed representation of DNA primary sequences. J. Chem. Inf. Comput. Sci., 2000, 40, 50-56
39. Randic, M.; Balaban, A. T. On a four-dimensional representation of DNA primary sequences. J. Chem. Inf. Comput. Sci., 2003, 43, 532-539
40. Perez, M. A.; Sanz, M. B.; Torres, L. R.; Avalos, R. G.; Gonzalez, M. P.; Diaz, H. G. A topological sub-structural approach for predicting human intestinal absorption of drugs. Eur. J. Med. Chem., 2004, 39, 905-916
41. Agüero-Chapin, G.; Gonzalez-Diaz, H.; Molina, R.; Varona-Santos, J.; Uriarte, E.; Gonzalez-Diaz, Y. Novel 2D maps and coupling numbers for protein sequences. The first QSAR study of polygalacturonases; isolation and prediction of a novel sequence from Psidium guajava L. FEBS Lett., 2006, 580 723-730.
42. Devillers, J.; Balaban, A. T. Topological Indices and Related Descriptors in QSAR and QSPR. Gordon and Breach: The Netherlands 1999.
43. Barabasi, A. L.; Bonabeau, E. Scale-free networks. Sci. Am., 2003, 288, 60-69
44. Balaban, A. T.; Basak, S. C.; Beteringhe, A.; Mills, D.; Supuran, C. T. QSAR study using topological indices for inhibition of carbonic anhydrase II by sulfanilamides and Schiff bases. Mol. Divers, 2004, 8, 401-412
45. Barabasi, A. L.; Oltvai, Z. N. Network biology: understanding the cell's functional organization. Nat. Rev. Genet., 2004, 5, 101-113
46. Barabasi, A. L. Sociology. Network theory-the emergence of the creative enterprise. Science, 2005, 308, 639-641
47. Ferino, G.; Gonzalez-Diaz, H.; Delogu, G.; Podda, G.; Uriarte, E. Using spectral moments of spiral networks based on PSA/mass spectra outcomes to derive quantitative proteome-disease relationships (QPDRs) and predicting prostate cancer. Biochem. Biophys. Res. Commun., 2008, 372, 320-325
48. Gonzalez-Diaz, H.; Gonzalez-Diaz, Y.; Santana, L.; Ubeira, F. M.; Uriarte, E. Proteomics, networks and connectivity indices. Proteomics, 2008, 8, 750-778
49. Munteanu, C. R.; Magalhaes, A. L.; Uriarte, E.; Gonzalez-Diaz, H. Multi-target QPDR classification model for human breast and colon cancer-related proteins using star graph topological indices. J. Theor. Biol., 2009, 257, 303-311
50. Vilar, S.; Gonzalez-Diaz, H.; Santana, L.; Uriarte, E. A network-QSAR model for prediction of genetic-component biomarkers in human colorectal cancer. J. Theor. Biol., 2009, 261, 449-458
51. Vilar, S.; Gonzalez-Diaz, H.; Santana, L.; Uriarte, E. QSAR model for alignment-free prediction of human breast cancer biomarkers based on electrostatic potentials of protein pseudofolding HPlattice networks. J. Comput. Chem., 2008, 29, 2613-2622
52. González-Díaz, H.; Ferino, G.; Munteanu, C. R.; Vilar, S.; Uriarte, E. In An Omics Perspective of Cancer, Cho, W.C.S.; Ed.; Springer Science+Business Media B.V., 2009.
53. González-Díaz, H.; Ferino, G.; Podda, G.; Uriarte, E. Discriminating Prostate Cancer Patients from control group with connectivity indices. ECSOC, 2008, 12, G1:1-10.
54. Ferino, G.; Delogu, G.; Podda, G.; Uriarte, E; González- Díaz, H. Quantitative Proteome-Disease Relationships (QPDRs) in clinical chemistry: prediction of prostate cancer with spectral moments of PSA/MS star networks, in clinical chemistry research. Mitchem, B.H.; Sharnham, Ch. L.; Eds. Nova Science Publisher: NY 2009.
55. Van Waterbeemd, H. In Method and Principles in Medicinal Chemistry, Manhnhold, R.; Krogsgaard-Larsen, P.; Timmerman, H.; Van Waterbeemd, H.; Eds.; Wiley-VCH: New York, 1995; Vol. 2, pp. 283-293.
56. Diederich, J. Artificial neural networks: concept learning. IEEE Press Piscataway, NJ, USA 1990.
57. Byvatov, E.; Schneider, G. Support vector machine applications in bioinformatics. Appl. Bioinformatics, 2003, 2, 67-77.
58. Eberbach, E. Toward a theory of evolutionary computation. Biosystems, 2005, 82, 1-19.
59. Rowland, J. J. Model selection methodology in supervised learning with evolutionary computation. Biosystems, 2003, 72, 187-196
60. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T. Gene Ontology: tool for the unification of biology. Nat. Genet., 2000, 25, 25-29.
61. Gómez-Pérez, A.; Fernández-López, M.; Corcho, O. Ontological Engineering: With Examples from the Areas of Knowledge Management, E-Commerce and the Semantic Web. Springer, USA, 2004.
62. Gruber, T. R. Toward principles for the design of ontologies used for knowledge sharing. Int. J. Hum. Comput. Stud., 1995, 43, 907-928.
63. Ashburner, M.; Ball, C. A.; Blake, J. A.; Botstein, D.; Butler, H.; Cherry, J. M.; Davis, A. P.; Dolinski, K.; Dwight, S. S.; Eppig, J. T.; Harris, M. A.; Hill, D. P.; Issel-Tarver, L.; Kasarskis, A.; Lewis, S.; Matese, J. C.; Richardson, J. E.; Ringwald, M.; Rubin, G. M.; Sherlock, G. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet., 2000, 25, 25-29
64. Smith, B. In The blackwell guide to the philosophy of computing and information, L. Floridi, Ed.; Blackwell Publishers: Oxford, 2003.
65. Yu, A. C. Methods in biomedical ontology. J. Biomed. Inform., 2006, 39, 252-266.
66. Neches, R.; Fikes, R.; Finin, T. W.; Gruber, T. R.; Patil, R.; Senator, T. E.; Swartout, W. R. Enabling technology for knowledge sharing. AI Magazine, 1991, 12, 36-56.
67. Gruber, T. R. A translation approach to portable ontology specifications. Knowledge Acquisition, 1993, 5, 199-220.
68. Studer, R.; Benjamins, V. R.; Fensel, D. Knowledge engineering: principles and methods. Data Knowledge Eng., 1998, 25, 161-197.
69. Guarino, N. In Formal Ontology in Information Systems; IOS Press: Trento, Italy, 1998; Vol. 98, pp. 3-15.
70. Smith, B.; Ceusters, W.; Klagges, B.; Köhler, J.; Kumar, A.; Lomax, J.; Mungall, C.; Neuhaus, F.; Rector, A.; Rosse, C. Relations in biomedical ontologies. Genome Biol., 2005, 6, R46.
71. Lassila, O.; McGuinness, D. The Role of Frame-Based Representation on the Semantic Web, Linköping Electronic Articles in Computer and Information Science, 2001, 6 (2001).
72. Uschold, M.; Gruninger, M. Ontologies and semantics for seamless connectivity. ACM SIGMOD Record, 2004, 33, 58-64.
73. OWL Web Ontology Language. Overview. http://www.w3.org/TR/owl-features/ (Accessed February 22, 2010).
74. Ashburner, M.; Lewis, S. On ontologies for biologists: the Gene Ontology - untangling the web. Novartis Found Symposium, 2002, 247, 66-80.
75. Stevens, R.; Goble, C. A.; Bechhofer, S. Ontology-based knowledge representation for bioinformatics. Brief. Bioinform., 2000, 1, 398-414.
76. Alonso-Calvo, R.; Maojo, V.; Billhardt, H.; Martin-Sanchez, F.; Garcia-Remesal, M.; Perez-Rey, D. An agent- and ontology-based system for integrating public gene, protein, and disease databases. J. Biomed. Inform., 2007, 40, 17-29.
77. Maojo, V.; Garcia-Remesal, M.; Billhardt, H.; Alonso-Calvo, R.; Perez-Rey, D.; Martin-Sanchez, F. Designing new methodologies for integrating biomedical information in clinical trials. Methods Inf. Med., 2006, 45, 180-185 (Pubitemid 44047761)
78. de la Calle, G.; Garcia-Remesal, M.; Chiesa, S.; de la Iglesia, D.; Maojo, V. BIRI: a new approach for automatically discovering and indexing available public bioinformatics resources from the literature. BMC Bioinformatics, 2009, 10, 320.
79. Blake, J. Bio-ontologies - fast and furious. Nat. Biotechnol., 2004, 22, 773-774.
80. Shah, N. H.; Rubin, D. L.; Espinosa, I.; Montgomery, K.; Musen, M. A. Annotation and query of tissue microarray data using the NCI Thesaurus. BMC Bioinformatics, 2007, 8, 296.
81. Noy, N. F.; Shah, N. H.; Whetzel, P. L.; Dai, B.; Dorf, M.; Griffith, N.; Jonquet, C.; Rubin, D. L.; Storey, M. A.; Chute, C. G. BioPortal: ontologies and integrated data resources at the click of a mouse. Nucleic Acids Res., 2009, 37, W170-W173.
82. Gusev, Y.; Schmittgen, T.; Lerner, M.; Postier, R.; Brackett, D. Computational analysis of biological functions and pathways col lectively targeted by co-expressed microRNAs in cancer. BMC Bioinformatics, 2007, 8, S16.
83. Whetzel, P. L.; Parkinson, H.; Causton, H. C.; Fan, L.; Fostel, J.; Fragoso, G.; Game, L.; Heiskanen, M.; Morrison, N.; Rocca-Serra, P.; Sansone, S. A.; Taylor, C.; White, J.; Stoeckert, C. J., Jr. The MGED Ontology: a resource for semantics-based description of microarray experiments. Bioinformatics, 2006, 22, 866-873
84. Smith, B.; Ashburner, M.; Rosse, C.; Bard, J.; Bug, W.; Ceusters, W.; Goldberg, L. J.; Eilbeck, K.; Ireland, A.; Mungall, C. J. The OBO Foundry: coordinated evolution of ontologies to support biomedical data integration. Nat. Biotechnol., 2007, 25, 1251.
85. National Center for Biomedical Ontology. BioPortal Website. http://bioportal.bioontology.org (Accessed February 19, 2010).
86. Moro, S.; Braiuca, P.; Deflorian, F.; Ferrari, C.; Pastorin, G.; Cacciari, B.; Baraldi, P. G.; Varani, K.; Borea, P. A.; Spalluto, G. Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study. J. Med. Chem., 2005, 48, 152-162
87. National Cancer Institute. Enterprise Vocabulary Services. http://www.cancer.gov/cancertopics/terminologyresources (Accessed February 17, 2010).
88. Bodenreider, O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nucleic Acids Res., 2004, 32, 267-270.
89. Dheyongera, J. P.; Geldenhuys, W. J.; Dekker, T. G.; Van der Schyf, C. J. Synthesis, biological evaluation, and molecular modeling of novel thioacridone derivatives related to the anticancer alkaloid acronycine. Bioorg. Med. Chem., 2005, 13, 689-698
90. Lander, E. S.; Linton, L. M.; Birren, B.; Nusbaum, C.; Zody, M. C.; Baldwin, J.; Devon, K.; Dewar, K.; Doyle, M.; FitzHugh, W. Initial sequencing and analysis of the human genome. Nature, 2001, 409, 860-921.
91. Stratton, M. R.; Campbell, P. J.; Futreal, P. A. The cancer genome. Nature, 2009, 458, 719-724.
92. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 2010, 38, D355-D360.
93. Pathguide: the pathway resource list. Available from: http://www.pathguide.org (Accessed February 19, 2010).
94. Luciano, J. S. PAX of mind for pathway researchers. Drug Discov. Today, 2005, 10, 937-942.
95. Kanehisa, M.; Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res., 2000, 28, 27-30.
96. Caspi, R.; Foerster, H.; Fulcher, C. A.; Kaipa, P.; Krummenacker, M.; Latendresse, M.; Paley, S.; Rhee, S. Y.; Shearer, A. G.; Tissier, C. The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res., 2008, 36, D623-D631.
97. Lin, G.; Liu, Y. C.; Lin, Y. F.; Wu, Y. G. Ortho effects in quantitative structure-activity relationships for acetylcholinesterase inhibition by aryl carbamates. J. Enzyme Inhib. Med. Chem., 2004, 19, 395-401.
98. Joshi-Tope, G.; Gillespie, M.; Vastrik, I.; D'Eustachio, P.; Schmidt, E.; de Bono, B.; Jassal, B.; Gopinath, G. R.; Wu, G. R.; Matthews, L. Reactome: a knowledgebase of biological pathways. Nucleic Acids Res., 2005, 33, D428-D432.
99. INOH Pathway Database, Integrating Network Objects with Hierarchies. Available from: www.inoh.org (Accessed).
100. Yamamoto, S.; Asanuma, T.; Takagi, T.; Fukuda, K. I. The molecule role ontology: an ontology for annotation of signal transduction pathway molecules in the scientific literature. Comp. Funct. Genomics, 2004, 5, 528-536
101. Mi, H.; Guo, N.; Kejariwal, A.; Thomas, P. D. PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res., 2007, 35, D247-D252.
102. Morley, M.; Arcaro, M.; Burdick, J.; Yonescu, R.; Reid, T.; Kirsch, I. R.; Cheung, V. G. GenMapDB: a database of mapped human BAC clones. Nucleic Acids Res., 2001, 29, 144-147.
103. Demir, E.; Babur, O.; Dogrusoz, U.; Gursoy, A.; Nisanci, G.; Cetin-Atalay, R.; Ozturk, M. PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways. Bioinformatics, 2002, 18, 996-1003.
104. Okuda, S.; Yamada, T.; Hamajima, M.; Itoh, M.; Katayama, T.; Bork, P.; Goto, S.; Kanehisa, M. KEGG Atlas mapping for global analysis of metabolic pathways. Nucleic Acids Res., 2008, 36, W423-W426.
105. Green, M. L.; Karp, P. D. The outcomes of pathway database computations depend on pathway ontology. Nucleic Acids Res., 2006, 34, 3687-3697.
106. de La Cruz, N.; Bromberg, S.; Pasko, D.; Shimoyama, M.; Twigger, S.; Chen, J.; Chen, C. F.; Fan, C.; Foote, C.; Gopinath, G. R. The Rat Genome Database (RGD): developments towards a phenome database. Nucleic Acids Res., 2005, 33, D485-D491.
107. Twigger, S.; Lu, J.; Shimoyama, M.; Chen, D.; Pasko, D.; Long, H.; Ginster, J.; Chen, C. F.; Nigam, R.; Kwitek, A.; Eppig, J.; Maltais, L.; Maglott, D.; Schuler, G.; Jacob, H.; Tonellato, P. J. Rat Genome Database (RGD): mapping disease onto the genome. Nucleic Acids Res., 2002, 30, 125-128
108. Niu, J.; Huang, L.; Chen, J.; Yu, G.; Schramm, K. W. Quantitative structure-property relationships on photolysis of PCDD/Fs adsorbed to spruce (Picea abies (L.) Karst.) needle surfaces under sunlight irradiation. Chemosphere, 2005, 58, 917-924
109. Kanehisa, M.; Araki, M.; Goto, S.; Hattori, M.; Hirakawa, M.; Itoh, M.; Katayama, T.; Kawashima, S.; Okuda, S.; Tokimatsu, T. KEGG for linking genomes to life and the environment. Nucleic Acids Res., 2008, 36, D480-D484.
110. Behrens, J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev., 1999, 18, 15-30.
111. Adjei, A. A. Blocking oncogenic Ras signaling for cancer therapy. J. Natl. Cancer Inst., 2001, 93, 1062-1074
112. Roman, C.; Saha, D.; Beauchamp, R. TGF-beta and colorectal carcinogenesis. Microsc. Res. Tech., 2001, 52, 450-457
113. Grady, W. M. Genomic instability and colon cancer. Cancer Metastasis Rev., 2004, 23, 11-27.
114. Mehlen, P.; Fearon, E. R. Role of the dependence receptor DCC in colorectal cancer pathogenesis. J. Clin. Oncol., 2004, 22, 3420-3428
115. Behrens, J. The role of the Wnt signalling pathway in colorectal tumorigenesis. Biochem. Soc. Trans., 2005, 33, 672-675
116. Takayama, T.; Miyanishi, K.; Hayashi, T.; Sato, Y.; Niitsu, Y. Colorectal cancer: genetics of development and metastasis. J. Gastroenterol., 2006, 41, 185-192
117. Watson, A. J. An overview of apoptosis and the prevention of colorectal cancer. Crit. Rev. Oncol. Hematol., 2006, 57, 107-121
118. Caspi, R.; Foerster, H.; Fulcher, C. A.; Kaipa, P.; Krummenacker, M.; Latendresse, M.; Paley, S.; Rhee, S. Y.; Shearer, A. G.; Tissier, C.; Walk, T. C.; Zhang, P.; Karp, P. D. The MetaCyc Database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res., 2008, 36, D623-31.
119. Mukherjee, S.; Mukherjee, A.; Saha, A. QSAR studies with E-state index: predicting pharmacophore signals for estrogen receptor binding affinity of triphenylacrylonitriles. Biol. Pharm. Bull., 2005, 28, 154-157
120. Hucka, M.; Finney, A.; Sauro, H. M.; Bolouri, H.; Doyle, J. C.; Kitano, H. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics, 2003, 19, 524-531.
121. Hermjakob, H.; Montecchi-Palazzi, L.; Bader, G.; Wojcik, J.; Salwinski, L.; Ceol, A.; Moore, S.; Orchard, S.; Sarkans, U.; von Mering, C. The HUPO PSI's molecular interaction format - a community standard for the representation of protein interaction data. Nat. Biotechnol., 2004, 22, 177-183.
122. Lloyd, C. M.; Halstead, M. D. B.; Nielsen, P. F. CellML: its future, present and past. Prog. Biophys. Mol. Biol., 2004, 85, 433-450.
123. Stromback, L.; Lambrix, P. Representations of molecular pathways: an evaluation of SBML, PSI MI and BioPAX. Bioinformatics, 2005, 21, 4401-4407.
124. Karnachi, P. S.; Brown, F. K. Practical approaches to efficient screening: information-rich screening protocol. J. Biomol. Screen, 2004, 9, 678-686
125. Suhre, W. M.; Ekins, S.; Chang, C.; Swaan, P. W.; Wright, S. H. Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Mol. Pharmacol., 2005, 67, 1067-1077
126. Sioutos, N.; Coronado, S.; Haber, M. W.; Hartel, F. W.; Shaiu, W. L.; Wright, L. W. NCI Thesaurus: A semantic model integrating cancer-related clinical and molecular information. J. Biomed. Infor., 2007, 40, 30-43.
127. Gonzalez-Diaz, H.; Perez-Montoto, L. G.; Duardo-Sanchez, A.; Paniagua, E.; Vazquez-Prieto, S.; Vilas, R.; Dea-Ayuela, M. A.; Bolas-Fernandez, F.; Munteanu, C. R.; Dorado, J.; Costas, J.; Ubeira, F. M. Generalized lattice graphs for 2D-visualization of biological information. J. Theor. Biol., 2009, 261, 136-147
128. Harary, F. Graph Theory, Addison-Wesley, Reading: MA, Philippines 1969.
129. Randic, M.; Zupan, J.; Vikic-Topic, D. On representation of proteins by star-like graphs. J. Mol. Graph. Model, 2007, 290-305.
130. González-Díaz, H.; Molina-Ruiz, R.; Hernandez, I. MARCHINSIDE version 3.0 (MARkov CHains INvariants for SImulation & DEsign); Windows supported version under request to the main author contact email: gonzalezdiazh@yahoo.es, 2007.
131. Munteanu, C. R.; Gonzáles-Diáz, H. S2SNet - Sequence to Star Network, Software Reg. No. 03/2008/1338, Santiago de Compostela, Spain, 2008.
132. Junker, B. H.; Koschuetzki, D.; Schreiber, F. Exploration of biological network centralities with CentiBiN, BMC Bioinformatics, 2006, 7, 219.
133. Batagelj, V.; Mrvar, A. Pajek - Program for Large Network Analysis. Connections, 1998, 21, 47-57.
134. Sjoblom, T.; Jones, S.; Wood, L. D.; Parsons, D. W.; Lin, J.; Barber, T. D.; Mandelker, D.; Leary, R. J.; Ptak, J.; Silliman, N.; Szabo, S.; Buckhaults, P.; Farrell, C.; Meeh, P.; Markowitz, S. D.; Willis, J.; Dawson, D.; Willson, J. K.; Gazdar, A. F.; Hartigan, J.; Wu, L.; Liu, C.; Parmigiani, G.; Park, B. H.; Bachman, K. E.; Papadopoulos, N.; Vogelstein, B.; Kinzler, K. W.; Velculescu, V. E. The consensus coding sequences of human breast and colorectal cancers. Science, 2006, 314, 268-274
135. Dobson, P. D.; Cai, Y. D.; Stapley, B. J.; Doig, A. J. Prediction of protein function in the absence of significant sequence similarity. Curr. Med. Chem., 2004, 11, 2135-2142
136. Dobson, P. D.; Doig, A. J. Predicting enzyme class from protein structure without alignments. J. Mol. Biol., 2005, 345, 187-199
137. StatSoft.Inc. STATISTICA, (data analysis software system), version 6.0, www.statsoft.com, 2002.
138. Pace, N. R. The universal nature of biochemistry. Proc. Natl. Acad. Sci. U S A, 2001, 98, 805-808
139. Pasemann, F. Complex dynamics and the structure of small neural networks. Network, 2002, 13, 195-216.
140. Kim, Y. S.; Maruvada, P.; Milner, J. A. Metabolomics in biomarker discovery: future uses for cancer prevention. Future Oncol., 2008, 4, 93-102.
141. Serkova, N. J.; Glunde, K. Metabolomics of cancer. Methods Mol. Biol., 2009, 520, 273-295
142. Ludwig, C.; Ward, D. G.; Martin, A.; Viant, M. R.; Ismail, T.; Johnson, P. J.; Wakelam, M. J.; Gunther, U. L. Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn. Reson. Chem., 2009, 47 Suppl 1, S68-73.
143. Griffin, J. L.; Kauppinen, R. A. Tumour metabolomics in animal models of human cancer. J. Proteome Res., 2007, 6, 498-505.
144. Jordan, K. W.; Nordenstam, J.; Lauwers, G. Y.; Rothenberger, D. A.; Alavi, K.; Garwood, M.; Cheng, L. L. Metabolomic characterization of human rectal adenocarcinoma with intact tissue magnetic resonance spectroscopy. Dis. Colon. Rectum., 2009, 52, 520-525
145. Wishart, D. S.; Tzur, D.; Knox, C.; Eisner, R.; Guo, A. C.; Young, N.; Cheng, D.; Jewell, K.; Arndt, D.; Sawhney, S.; Fung, C.; Nikolai, L.; Lewis, M.; Coutouly, M. A.; Forsythe, I.; Tang, P.; Shrivastava, S.; Jeroncic, K.; Stothard, P.; Amegbey, G.; Block, D.; Hau, D. D.; Wagner, J.; Miniaci, J.; Clements, M.; Gebremedhin, M.; Guo, N.; Zhang, Y.; Duggan, G. E.; Macinnis, G. D.; Weljie, A. M.; Dowlatabadi, R.; Bamforth, F.; Clive, D.; Greiner, R.; Li, L.; Marrie, T.; Sykes, B. D.; Vogel, H. J.; Querengesser, L. HMDB: the Human metabolome database. Nucleic Acids Res., 2007, 35, D521-6.
146. Goh, K. I.; Cusick, M. E.; Valle, D.; Childs, B.; Vidal, M.; Barabasi, A. L. The human disease network. Proc. Natl. Acad. Sci. U S A, 2007, 104, 8685-8690
147. Borodina, I.; Nielsen, J. From genomes to in silico cells via metabolic networks. Curr. Opin. Biotechnol., 2005, 16, 350-355
148. Gianchandani, E. P.; Brautigan, D. L.; Papin, J. A. Systems analyses characterize integrated functions of biochemical networks. Trends Biochem. Sci., 2006, 31, 284-291
149. Duarte, N. C.; Becker, S. A.; Jamshidi, N.; Thiele, I.; Mo, M. L.; Vo, T. D.; Srivas, R.; Palsson, B. O. Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. U S A, 2007, 104, 1777-1782
150. Lee, D. S.; Park, J.; Kay, K. A.; Christakis, N. A.; Oltvai, Z. N.; Barabasi, A. L. The implications of human metabolic network topology for disease comorbidity. Proc. Natl. Acad. Sci. U S A, 2008, 105, 9880-9885
151. Edelman, L. B.; Eddy, J. A.; Price, N. D. In Wiley Interdisciplinary Reviews: Systems Biology and Medicine; John Wiley & Sons, Inc.: IL, USA, 2010; Vol. DOI: 10.1002/wsbm.75.
152. Warburg, O. On respiratory impairment in cancer cells, Science, 1956, 124, 269-270
153. Ruckenstuhl, C.; Buttner, S.; Carmona-Gutierrez, D.; Eisenberg, T.; Kroemer, G.; Sigrist, S. J.; Frohlich, K. U.; Madeo, F. The Warburg effect suppresses oxidative stress induced apoptosis in a yeast model for cancer. PLoS One, 2009, 4, e4592.
154. Hsu, P. P.; Sabatini, D. M. Cancer cell metabolism: Warburg and beyond. Cell, 2008, 134, 703-707
155. Kanehisa, M.; Goto, S.; Furumichi, M.; Tanabe, M.; Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res., 2010, 38, D355-60.
156. Kitisin, K.; Mishra, L. Molecular biology of colorectal cancer: new targets. Semin. Oncol., 2006, 33, S14-23.
157. Li, G. M. Mechanisms and functions of DNA mismatch repair. Cell Res., 2008, 18, 85-98.
158. Jacob, S.; Praz, F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie, 2002, 84, 27-47.
159. Polakis, P. Wnt signaling and cancer. Genes Dev., 2000, 14, 1837-1851
160. Klaus, A.; Birchmeier, W. Wnt signalling and its impact on development and cancer. Nat. Rev. Cancer, 2008, 8, 387-398
161. Bienz, M.; Clevers, H. Linking colorectal cancer to Wnt signaling, Cell, 2000, 103, 311-320
162. Katoh, M.; Katoh, M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res., 2007, 13, 4042-4045
163. Barker, N.; Clevers, H. Catenins, Wnt signaling and cancer. Bioessays, 2000, 22, 961-965
164. Xu, Y.; Pasche, B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum. Mol. Genet., 2007, 16 Spec No 1, R14-20.
165. Gordon, K. J.; Blobe, G. C. Role of transforming growth factorbeta superfamily signaling pathways in human disease. Biochim. Biophys. Acta., 2008, 1782, 197-228.
166. Barault, L.; Veyrie, N.; Jooste, V.; Lecorre, D.; Chapusot, C.; Ferraz, J. M.; Lievre, A.; Cortet, M.; Bouvier, A. M.; Rat, P.; Roignot, P.; Faivre, J.; Laurent-Puig, P.; Piard, F. Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH kinase) signaling network correlate with poor survival in a population-based series of colon cancers. Int. J. Cancer, 2008, 122, 2255-2259
167. Preto, A.; Figueiredo, J.; Velho, S.; Ribeiro, A. S.; Soares, P.; Oliveira, C.; Seruca, R. BRAF provides proliferation and survival signals in MSI colorectal carcinoma cells displaying BRAF(V600E) but not KRAS mutations. J. Pathol., 2008, 214, 320-327
168. Gulmann, C.; Sheehan, K. M.; Conroy, R. M.; Wulfkuhle, J. D.; Espina, V.; Mullarkey, M. J.; Kay, E. W.; Liotta, L. A.; Petricoin, E. F., 3rd. Quantitative cell signalling analysis reveals down-regulation of MAPK pathway activation in colorectal cancer. J. Pathol., 2009, 218, 514-519
169. Castagnola, P.; Giaretti, W. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. Biochim Biophys Acta, 2005, 1756, 115-125
170. Lupulescu, A. Cancer Cell Metabolism and Cancer Treatment, Hardwood Acedemic Publishers, The Gordon and Breach Publishing Group: Amsterdam, The Netherlands 2001.
171. Morton, K. S. Enzymes in colon cancer. 〈I〉General information〈/I〉. Cancer, 1975, 36, 2334-2336.
172. Denkert, C.; Budczies, J.; Weichert, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M.; Fiehn, O. Metabolite profiling of human colon carcinoma - deregulation of TCA cycle and amino acid turnover. Mol. Cancer, 2008, 7, 72.
173. Gratio, V.; Beaufort, N.; Seiz, L.; Maier, J.; Virca, G. D.; Debela, M.; Grebenchtchikov, N.; Magdolen, V.; Darmoul, D. Kallikrein- Related Peptidase 4. A new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells. Am. J. Pathol., 2010, 176(3), 1452-1461.
174. Nibbe, R. K.; Markowitz, S.; Myeroff, L.; Ewing, R.; Chance, M. R. Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer. Mol. Cell Proteomics, 2009, 8, 827-845
175. Nibbe, R. K.; Koyuturk, M.; Chance, M. R. An integrative -omics approach to identify functional sub-networks in human colorectal cancer. PLoS Comput. Biol., 2010, 6, e1000639.
176. Ideker, T.; Sharan, R. Protein networks in disease. Genome Res., 2008, 18, 644-652
177. Prasad, T. S.; Kandasamy, K.; Pandey, A. Human protein reference database and human proteinpedia as discovery tools for systems biology. Methods Mol. Biol., 2009, 577, 67-79.
178. Friedman, D. B.; Hill, S.; Keller, J. W.; Merchant, N. B.; Levy, S. E.; Coffey, R. J.; Caprioli, R. M. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics, 2004, 4, 793-811.
179. Kohler, S.; Bauer, S.; Horn, D.; Robinson, P. N. Walking the interactome for prioritization of candidate disease genes. Am. J. Hum. Genet., 2008, 82, 949-958
180. Chen, J.; Aronow, B. J.; Jegga, A. G. Disease candidate gene identification and prioritization using protein interaction networks. BMC Bioinformatics, 2009, 10, 73.
181. Goehler, H.; Lalowski, M.; Stelzl, U.; Waelter, S.; Stroedicke, M.; Worm,
182. Calvano, S. E.; Xiao, W.; Richards, D. R.; Felciano, R. M.; Baker, H. V.; Cho, R. J.; Chen, R. O.; Brownstein, B. H.; Cobb, J. P.; Tschoeke, S. K.; Miller-Graziano, C.; Moldawer, L. L.; Mindrinos, M. N.; Davis, R. W.; Tompkins, R. G.; Lowry, S. F. A network-based analysis of systemic inflammation in humans. Nature, 2005, 437, 1032-1037
183. Pujana, M. A.; Han, J. D.; Starita, L. M.; Stevens, K. N.; Tewari, M.; Ahn, J. S.; Rennert, G.; Moreno, V.; Kirchhoff, T.; Gold, B.; Assmann, V.; Elshamy, W. M.; Rual, J. F.; Levine, D.; Rozek, L. S.; Gelman, R. S.; Gunsalus, K. C.; Greenberg, R. A.; Sobhian, B.; Bertin, N.; Venkatesan, K.; Ayivi-Guedehoussou, N.; Sole, X.; Hernandez, P.; Lazaro, C.; Nathanson, K. L.; Weber, B. L.; Cusick, M. E.; Hill, D. E.; Offit, K.; Livingston, D. M.; Gruber, S. B.; Parvin, J. D.; Vidal, M. Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat. Genet, 2007, 39, 1338-1349
184. Ortutay, C.; Vihinen, M. Identification of candidate disease genes by integrating Gene Ontologies and protein-interaction networks: case study of primary immunodeficiencies. Nucleic Acids Res., 2009, 37, 622-628
185. Huang, H.; Li, J.; Chen, J. Y. Disease gene-fishing in molecular interaction networks: A case study in colorectal cancer. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2009, 1, 6416-6419
186. Ahn, A. C.; Tewari, M.; Poon, C. S.; Phillips, R. S. The clinical applications of a systems approach. PLoS Med., 2006, 3, e209.
187. Morrison, J. L.; Breitling, R.; Higham, D. J.; Gilbert, D. R. GeneRank: using search engine technology for the analysis of microarray experiments. BMC Bioinformatics, 2005, 6, 233.
188. Hamosh, A.; Scott, A. F.; Amberger, J. S.; Bocchini, C. A.; McKusick, V. A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res., 2005, 33, D514-7.
189. Baxevanis, A. D. Searching Online Mendelian Inheritance in Man (OMIM) for information for genetic loci involved in human disease. Curr. Protoc. Bioinformatics, 2002, Chapter 1, Unit 12.
190. Rhodes, D. R.; Kalyana-Sundaram, S.; Mahavisno, V.; Varambally, R.; Yu, J.; Briggs, B. B.; Barrette, T. R.; Anstet, M. J.; Kincead- Beal, C.; Kulkarni, P.; Varambally, S.; Ghosh, D.; Chinnaiyan, A. M. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia, 2007, 9, 166-180
191. Mattingly, C. J.; Rosenstein, M. C.; Colby, G. T.; Forrest, J. N., Jr.; Boyer, J. L. The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. J Exp. Zool A Comp. Exp. Biol., 2006, 305, 689-692
192. Chen, J. Y.; Shen, C.; Sivachenko, A. Y. Mining Alzheimer disease relevant proteins from integrated protein interactome data. Pac. Symp. Biocomput., 2006, 367-378
193. Maitland, M. L.; DiRienzo, A.; Ratain, M. J. Interpreting disparate responses to cancer therapy: the role of human population genetics. J. Clin. Oncol., 2006, 24, 2151-2157
194. Hennessy, B. T.; Smith, D. L.; Ram, P. T.; Lu, Y.; Mills, G. B. Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat. Rev. Drug Discov., 2005, 4, 988-1004.
195. Funke, S.; Brenner, H.; Chang-Claude, J. Pharmacogenetics in colorectal cancer: a systematic review. Pharmacogenomics, 2008, 9, 1079-1099
196. Gold, H. T.; Hall, M. J.; Blinder, V.; Schackman, B. R. Cost effectiveness of pharmacogenetic testing for uridine diphosphate glucuronosyltransferase 1A1 before irinotecan administration for metastatic colorectal cancer. Cancer, 2009, 115, 3858-3867
197. Helsby, N. A.; Lo, W. Y.; Sharples, K.; Riley, G.; Murray, M.; Spells, K.; Dzhelai, M.; Simpson, A.; Findlay, M. CYP2C19 pharmacogenetics in advanced cancer: compromised function independent of genotype. Br. J. Cancer., 2008, 99, 1251-1255
198. Zhang, W.; Gordon, M.; Schultheis, A. M.; Yang, D. Y.; Nagashima, F.; Azuma, M.; Chang, H. M.; Borucka, E.; Lurje, G.; Sherrod, A. E.; Iqbal, S.; Groshen, S.; Lenz, H. J. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. J. Clin. Oncol., 2007, 25, 3712-3718
199. Lievre, A.; Laurent-Puig, P. Genetics: Predictive value of KRAS mutations in chemoresistant CRC. Nat. Rev. Clin. Oncol., 2009, 6, 306-307
200. Rodriguez-Antona, C.; Gomez, A.; Karlgren, M.; Sim, S. C.; Ingelman-Sundberg, M. Molecular genetics and epigenetics of the cytochrome P450 gene family and its relevance for cancer risk and treatment. Hum. Genet., 2010, 127, 1-17.
201. Klein, T. E.; Chang, J. T.; Cho, M. K.; Easton, K. L.; Fergerson, R.; Hewett, M.; Lin, Z.; Liu, Y.; Liu, S.; Oliver, D. E.; Rubin, D. L.; Shafa, F.; Stuart, J. M.; Altman, R. B. Integrating genotype and phenotype information: an overview of the PharmGKB project. Pharmacogenetics research network and knowledge base. Pharmacogenomics J., 2001, 1, 167-170
202. Diasio, R. B.; Harris, B. E. Clinical pharmacology of 5-fluorouracil. Clin. Pharmacokinet., 1989, 16, 215-237
203. Miwa, M.; Ura, M.; Nishida, M.; Sawada, N.; Ishikawa, T.; Mori, K.; Shimma, N.; Umeda, I.; Ishitsuka, H. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur. J. Cancer, 1998, 34, 1274-1281
204. van Kuilenburg, A. B.; Meinsma, R.; Zonnenberg, B. A.; Zoetekouw, L.; Baas, F.; Matsuda, K.; Tamaki, N.; van Gennip, A. H. Dihydropyrimidinase deficiency and severe 5-fluorouracil toxicity. Clin. Cancer Res., 2003, 9, 4363-4367
205. Yuan, J.; Lv, H.; Peng, B.; Wang, C.; Yu, Y.; He, Z. Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer. Cancer Chemother. Pharmacol., 2009, 63, 1103-1110
206. Hagmann, W.; Jesnowski, R.; Faissner, R.; Guo, C.; Lohr, J. M. ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells. Pancreatology, 2009, 9, 136-144
207. Marsh, S.; McLeod, H.; Dolan, E.; Shukla, S. J.; Rabik, C. A.; Gong, L.; Hernandez-Boussard, T.; Lou, X. J.; Klein, T. E.; Altman, R. B. Platinum pathway. Pharmacogenet. Genomics, 2009, 19, 563-564
208. Meijer, C.; Timmer, A.; De Vries, E. G.; Groten, J. P.; Knol, A.; Zwart, N.; Dam, W. A.; Sleijfer, D. T.; Mulder, N. H. Role of metallothionein in cisplatin sensitivity of germ-cell tumours. Int. J. Cancer, 2000, 85, 777-781
209. Peters, U.; Preisler-Adams, S.; Hebeisen, A.; Hahn, M.; Seifert, E.; Lanvers, C.; Heinecke, A.; Horst, J.; Jurgens, H.; Lamprecht-Dinnesen, A. Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin. Anticancer Drugs, 2000, 11, 639-643
210. Lu, C.; Spitz, M. R.; Zhao, H.; Dong, Q.; Truong, M.; Chang, J. Y.; Blumenschein, G. R., Jr.; Hong, W. K.; Wu, X. Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinoma. Cancer, 2006, 106, 441-447
211. Chan, A. T.; Ogino, S.; Fuchs, C. S. Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. N. Engl. J. Med., 2007, 356, 2131-2142
212. Chan, A. T.; Tranah, G. J.; Giovannucci, E. L.; Hunter, D. J.; Fuchs, C. S. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J. Natl. Cancer Inst., 2005, 97, 457-460
213. Saif, M. W.; Katirtzoglou, N. A.; Syrigos, K. N. Capecitabine: an overview of the side effects and their management. Anticancer Drugs, 2008, 19, 447-464
214. Sharma, R.; Hoskins, J. M.; Rivory, L. P.; Zucknick, M.; London, R.; Liddle, C.; Clarke, S. J. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphisms and toxicity to capecitabine in advanced colorectal cancer patients. Clin. Cancer Res., 2008, 14, 817-825
215. Solomon, S. D.; McMurray, J. J.; Pfeffer, M. A.; Wittes, J.; Fowler, R.; Finn, P.; Anderson, W. F.; Zauber, A.; Hawk, E.; Bertagnolli, M. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N. Engl. J. Med., 2005, 352, 1071-1080
216. Karapetis, C. S.; Khambata-Ford, S.; Jonker, D. J.; O'Callaghan, C. J.; Tu, D.; Tebbutt, N. C.; Simes, R. J.; Chalchal, H.; Shapiro, J. D.; Robitaille, S.; Price, T. J.; Shepherd, L.; Au, H. J.; Langer, C.; Moore, M. J.; Zalcberg, J. R. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N. Engl. J. Med., 2008, 359, 1757-1765
217. Huang, R. S.; Duan, S.; Shukla, S. J.; Kistner, E. O.; Clark, T. A.; Chen, T. X.; Schweitzer, A. C.; Blume, J. E.; Dolan, M. E. Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am. J. Hum. Genet., 2007, 81, 427-437
218. Goode, E. L.; Potter, J. D.; Bigler, J.; Ulrich, C. M. Methionine synthase D919G polymorphism, folate metabolism, and colorectal adenoma risk. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 157-162
219. Zintzaras, E.; Ziogas, D. C.; Kitsios, G. D.; Papathanasiou, A. A.; Lau, J.; Raman, G. MTHFR gene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis. Pharmacogenomics, 2009, 10, 1285-1294
220. Gusella, M.; Frigo, A. C.; Bolzonella, C.; Marinelli, R.; Barile, C.; Bononi, A.; Crepaldi, G.; Menon, D.; Stievano, L.; Toso, S.; Pasini, F.; Ferrazzi, E.; Padrini, R. Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. Br. J. Cancer, 2009, 100, 1549-1557
221. Funke, S.; Timofeeva, M.; Risch, A.; Hoffmeister, M.; Stegmaier, C.; Seiler, C. M.; Brenner, H.; Chang-Claude, J. Genetic polymorphisms in GST genes and survival of colorectal cancer patients treated with chemotherapy. Pharmacogenomics, 11, 33-41.
222. García-Martín, E.; Pizarro, R. M.; Martínez, C.; Gutierrez-Martín, Y.; Pérez, G.; Jover, R.; Agúndez, J. A. Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8. Pharmacogenomics, 2006, 7, 575-585
223. Ye, J.; Williams, S. D.; Xu, Z. The association between social networks and colorectal cancer screening in American males and females: data from the 2005 Health Information National Trends Survey. Cancer Causes Control, 2009, 20, 1227-1233.
224. Wasserman, S.; Faust, K. Social Network Analysis: Methods and Applications, Cambridge University Press: New York 1994.
225. Junker, B. H.; Koschuetzki, D.; Schreiber, F. Exploration of biological network centralities with CentiBiN. BMC Bioinformatics, 2006, 7, 219.
226. González-Díaz, H.; Prado-Prado, F. J. Unified QSAR and network-based computational chemistry approach to antimicrobials, part 1: multispecies activity modelss for antifungals. J. Comput. Chem., 2008, 29(4), 656-667.
227. Kamada, T.; Kawai, S. An Algorithm for Drawing General Undirected Graphs. Infor. Processing Lett., 1988, 31, 7-15.
228. Bornholdt, S.; Schuster, H. G. Handbook of Graphs and Complex Networks: From the Genome to the Internet, WILEY-VCH GmbH & CO. KGa.: Wheinheim, 2003.
229. Moody, J. Matrix methods for calculating the triad census. Soc. Networks, 1998, 20, 291-299. (Pubitemid 128344460)
230. Vila, A.; Mosquera, R. A. Transferability in alkyl monoethers. II. Methyl and methylene fragments. J. Chem. Phys., 2001, 115, 1264-1273.